C07F 9/65312
Having the two nitrogen atoms in positions 1 and 2
Official title: {having the two nitrogen atoms in positions 1 and 2}
C07F9/65312 (Having the two nitrogen atoms in positions 1 and 2) appears on 42 US grants and 41 published applications in this corpus.
Search patents in C07F- Granted patents
- 42
- Published applications
- 41
- Assignees
- 32
- Inventors
- 105
- Latest grant
- 3 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 2 |
| 2005 | 2 | 1 |
| 2006 | 0 | 4 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 1 | 0 |
| 2010 | 2 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 4 | 6 |
| 2015 | 5 | 4 |
| 2016 | 2 | 2 |
| 2017 | 2 | 2 |
| 2018 | 4 | 3 |
| 2019 | 1 | 1 |
| 2020 | 2 | 2 |
| 2021 | 2 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands3 Oct 2023US 11,771,710 B2SRX Cardio, LLC
- Reagents useful for synthesizing rhodamine-labeled oligonucleotides9 Aug 2022US 11,407,773 B2Applied Biosystems, LLC
- Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same7 Dec 2021US 11,192,907 B2Centre National De La Recherche Scientifique
- Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands8 Jun 2021US 11,026,957 B2SRX Cardio, LLC
- Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof14 Jul 2020US 10,709,718 B2Metabasis Therapeutics, Inc.
- Small molecule compounds with phosphorylated aryl structures and use thereof26 Feb 2026US 2026/0055126 A1Hangzhou PhecdaMed Co., Ltd.
- Method to treat lipid dysregulation by modulating activity of proprotein convertase subtilisin/kexin type 9 (pcsk9) protein with small molecule ligands18 Apr 2024US 2024/0122951 A1SRX Cardio, LLC
- Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides30 Mar 2023US 2023/0096149 A1Applied Biosystems, LLC
- Aminopeptidase a inhibitors and pharmaceutical compositions comprising the same7 Oct 2021US 2021/0309678 A1Centre National De La Recherche Scientifique
- Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9) protein activity with small molecule ligands9 Sep 2021US 2021/0275551 A1SRX Cardio, LLC
Most cited
By later US patents
- Neprilysin inhibitors51US 8,871,792 B2Theravance Biopharma R&D IP, LLC · 2014
- Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors30US 6,498,151 B2Merck Frosst Canada, Inc. · 2002
- Reagents useful for synthesizing rhodamine-labeled oligonucleotides21US 9,040,674 B2Applied Biosystems, LLC · 2015
- Phosphate derivatives of diaryl 1,3,4-oxadiazolone13US 5,939,405 ABristol-Myers Squibb Company · 1999
- N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides12US 9,101,141 B2Bayer Interllectual Property GmbH · 2015